Committee of the Whole - Draft Proposals

  

Document Symbol 

Title or description 

E/CN.7/2021/L.2 

Statement of the Commission on Narcotic Drugs on the impact of the coronavirus disease (COVID-19) pandemic on the implementation of Member States’ joint commitments to address and counter all aspects of the world drug problem  

E/CN.7/2021/L.3/Rev.1

Facilitating access to comprehensive, scientific evidence-based drug demand reduction services and related measures, including for people impacted by social marginalization (Unedited version)

E/CN.7/2021/L.4/Rev.1

Promoting alternative development as a development-oriented drug control strategy, including in the context of the coronavirus disease (COVID-19) pandemic and its consequences 

E/CN.7/2021/L.5/Rev.1

Promoting scientific evidence-based, quality, affordable and comprehensive drug prevention, treatment, sustained recovery and related support services  

E/CN.7/2021/L.6/Rev.1

Improving data collection on, and responses to, the harmful effects of the non-medical use of pharmaceuticals containing narcotic drugs, psychotropic substances and new psychotropic substances

E/CN.7/2021/L.7

Provisional agenda for the sixty-fifth session of the Commission on Narcotic Drugs (draft decision)